Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.
Business Model:
Revenue: $0
Employees: 2-10
Address: 888 Prospect Street
City: La Jolla
State: CA
Zip: 92037
Country: US
Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Its programmes have the potential to dramatically improve patient care in major markets.
Contact Phone:
+12126711020
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/15/2017
Ticker Symbol:
ARTL
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2018 | Equity | $850.8k | 4/2019 | Equity | $857.4k | 1/2019 | Equity | $4.2M | 6/2019 | Post-IPO Equity | $8M | 7/2018 | Equity | $525.8k | 5/2020 | Post-IPO Equity | $55k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|